经导管主动脉瓣置换术前CT所示右心衰竭征象可预测术后死亡
回顾性分析2014至2018年505例连续患者中300例接受TAVR者,评估术前CT右心衰竭征象与术后1年全因死亡的关系。31例(10.3%)在术后1年内死亡,心包积液的存在与大小及主肺动脉增宽与死亡独立相关(AUC 0.758;95%CI 0.671-0.845),超声所示右室射血分数降低亦与死亡相关。
要点
- TAVR术前CT上的心包积液(存在与大小)与术后1年死亡相关(p=0.002)。
- 死亡组心包积液比例25.8%高于存活组9.3%,主肺动脉中位径3.2 cm大于存活组2.9 cm。
- 心包积液大小与肺动脉大小对死亡的预测独立于STS评分(AUC 0.758;95%CI 0.671-0.845)。
核心结论
- TAVR术前CT上右心衰竭相关征象(心包积液大小与肺动脉大小)与术后1年全因死亡增加相关,且独立于常规使用的STS评分。
研究设计与样本
- 回顾性研究,2014至2018年连续505例TAVR术前CT患者中300例接受TAVR;以术后1年全因死亡为主要结局,分为存活组(组1)与死亡组(组2),行多因素logistic回归(后退逐步法),并与超声心动图结果对照。
关键影像表现/征象
- 心包积液在存活组25例(9.3%)与死亡组8例(25.8%)中可见,其存在与大小与术后1年死亡强烈相关(p=0.002)。
- 主肺动脉增宽与死亡相关(p=0.024),存活组主肺动脉中位径2.9 cm(四分位距2.6-3.3 cm),死亡组3.2 cm(四分位距2.9-3.5 cm)。
- 超声心动图所示右室射血分数降低与术后1年死亡相关(p=0.034),进一步印证CT所见。
诊断标准与关键数值
- 多因素分析中心包积液大小与肺动脉大小为死亡的预测因素,独立于STS评分(AUC 0.758;95%CI 0.671-0.845)。
临床应用与阅片要点
- TAVR术前阅片时应关注心包积液的存在与大小以及主肺动脉径线,这些右心衰竭征象有助于术前进一步风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to determine whether imaging features of right heart failure seen on CT performed before transcatheter aorta valve replacement (TAVR) predict poor outcomes after the procedure.
MATERIALS AND METHODS: We retrospectively evaluated findings on CT performed before TAVR for 505 consecutive patients seen from 2014 to 2018. Of these patients, 300 underwent TAVR. Patient demographic characteristics and clinical and procedural data were recorded. Imaging features, including signs of right heart failure, left heart failure, lung disease, coronary artery disease, and concomitant mitral valve and apparatus calcifications were evaluated. The primary outcome was all-cause mortality at 1 year after TAVR. Patients were divided into two groups: those who were alive (group 1) and those who had died (group 2) by 1 year after TAVR. These groups were compared using the Mann-Whitney U test and the Pearson chi-square and Fisher exact tests when applicable. Multivariate logistic regression with a backward stepwise approach was performed. Results were correlated with echo-cardiography findings.
RESULTS: A total of 31 patients (10.3%) died within 1 year of TAVR. The presence and size of pericardial effusions were strongly associated with mortality within 1 year after TAVR (p = 0.002). Pericardial effusion was noted in 25 patients in group 1 (9.3%) and eight patients in group 2 (25.8%). Increased size of the main pulmonary artery was associated with death (p = 0.024), with a median main pulmonary artery size of 2.9 cm (interquartile range, 2.6-3.3 cm) in group 1 and 3.2 cm (interquartile range, 2.9-3.5 cm) in group 2. In multivariate analysis, pericardial effusion size and pulmonary artery size, both of which are indicative of right heart failure, were predictors of death, independent of the routinely used clinical Society of Thoracic Surgeons score (AUC, 0.758; 95% CI, 0.671-0.845). Depressed right ventricular ejection fraction, as identified on echocardiography, was associated with mortality within 1 year after TAVR (p = 0.034), further corroborating the CT findings.
CONCLUSION: Features related to right heart failure on pre-TAVR CT were associated with increased all-cause mortality within the first year after TAVR, even after adjustment for the Society of Thoracic Surgeons score. Such imaging findings can help in further risk stratification of patients before TAVR.
引用
- Hossain R, Chelala L, Sleilaty G, et al. Preprocedure CT Findings of Right Heart Failure as a Predictor of Mortality After Transcatheter Aortic Valve Replacement. AJR Am J Roentgenol. 2020. PMID: 33170737. doi:10.2214/AJR.20.22894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。